LIN, JIUNN:1213990 [22-002356]

林俊:1213990 [22-002356]

• 批准号: 10721073
• 金额: $ 0.96万
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-06-07 至 2022-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10721073
• 关键词: Address; Chemistry; Clinical Research; Clinical Trials; Consult; Contractor; Data; Development; Drug Kinetics; Electronic Mail; Experimental Designs; Formulation; Hour; Investigational Drugs; Lead; Lobular Neoplasia; Preparation; Protocols documentation; Reporting; Services; Teleconferences; Telephone; Time; United States National Institutes of Health; Work; assay development; design; drug development; drug discovery; drug metabolism; lead optimization; meetings; preclinical safety; programs

The Contractor shall provide this support while serving on NIH BPN Lead Development Teams. Lead Development Teams (LDT) meet for approximately two hours every one to two weeks via teleconference and each LDT project may require between three and ten hours weekly, inclusive of meeting and preparation time. The Contractor is expected to provide support services in a collaborative way. Lead Development Teams the Contractor is assigned to may work on a number of projects in the exploratory through preclinical safety stages. Some projects may proceed to investigational new drug and clinical trial stages. The Contractor shall provide consulting support services to the NIH Blueprint Neurotherapeutics Network as follows: • Evaluate pharmacokinetics study protocols and data to identify potential drug discovery and development challenges. Recommend strategies to address these challenges. • Develop plans to assist NIH BPN staff in strategically managing pharmacokinetic programs which facilitate assay development, exploratory chemistry, lead optimization, formulation activities, investigational new drug (IND) enabling, and clinical studies. • Assist NIH BPN staff to design investigative pharmacokinetics studies, including study strategy and experimental design. Provide advice regarding recommended study milestones and prepare milestone reports are needed. • Facilitate Lead Development Team discussions via telephone and email regarding assigned drug metabolism and pharmacokinetics efforts. • Analyze and interpret data for pharmacokinetics drug discovery, development, and translational projects.

承包商应在NIH BPN领导开发团队服务期间提供此支持。引领